Seminal new study on the role of circulating tumour-cell clusters in end-of-life cancer patients underpins strong rationale for cluster dissociation in late-stage disease

BASEL, Switzerland, Oct. 16, 2025 /PRNewswire/ -- Page Therapeutics is a Swiss biotech company focused on blocking cancer progression across different stages of disease by disrupting cell-cell adhesion in cancer cells, a mechanism found to be key for maintaining a proliferative state as...